{
    "Trade/Device Name(s)": [
        "Triage BNP Test for the Beckman Coulter Immunoassay Systems"
    ],
    "Submitter Information": "Biosite Incorporated",
    "510(k) Number": "K052789",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033383",
        "K021317",
        "K051787"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC"
    ],
    "Summary Letter Date": "January 23, 2006",
    "Summary Letter Received Date": "October 31, 2005",
    "Submission Date": "September 30, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1117"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "B-type natriuretic peptide (BNP)"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter Immunoassay Systems",
        "Access",
        "Access 2",
        "Synchron LXi 725",
        "UniCel Dxl 800"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Triage BNP Test for quantitative measurement of BNP in plasma on Beckman Coulter Immunoassay Systems.",
    "Indications for Use Summary": "Aids in diagnosis and assessment of severity of congestive heart failure and risk stratification of patients with acute coronary syndromes or heart failure using BNP measurement in plasma.",
    "fda_folder": "Clinical Chemistry"
}